日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Using a rich-lean transition procedure to evaluate putative antianxiety medications

采用富精益转型程序评估潜在的抗焦虑药物

Toegel, Forrest; Toegel, Cory; Rowlett, James K; Woods, Josh A; Zamarripa, Carlos Austin; Doyle, William S; Freeman, Kevin B; Huskinson, Sally L

A Systematic Review Protocol of the Barriers to Both Physical Activity and Obesity Counselling in the Secondary Care Setting as Reported by Healthcare Providers

医疗保健提供者报告的二级医疗机构中身体活动和肥胖咨询障碍的系统评价方案

Sooknarine-Rajpatty, Jaishri; B Auyeung, Austin; Doyle, Frank

A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer

AKT 抑制剂 MK-2206 联合激素疗法治疗绝经后雌激素受体阳性转移性乳腺癌患者的 I 期研究

Cynthia X Ma, Cesar Sanchez, Feng Gao, Robert Crowder, Michael Naughton, Timothy Pluard, Allison Creekmore, Zhanfang Guo, Jeremy Hoog, A Craig Lockhart, Austin Doyle, Charles Erlichman, Matthew J Ellis

Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: a report from the Children's Oncology Group

西妥木单抗联合替西罗莫司治疗复发性或难治性肉瘤的儿科患者和年轻成人的 II 期研究:儿童肿瘤学组的报告

Lars M Wagner, Maryam Fouladi, Atif Ahmed, Mark D Krailo, Brenda Weigel, Steven G DuBois, L Austin Doyle, Helen Chen, Susan M Blaney

Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia

口服 AKT 抑制剂 MK-2206 治疗急性髓性白血病的临床前和早期临床评估

Marina Y Konopleva, Roland B Walter, Stefan H Faderl, Elias J Jabbour, Zhihong Zeng, Gautam Borthakur, Xuelin Huang, Tapan M Kadia, Peter P Ruvolo, Jennie B Feliu, Hongbo Lu, Lakiesha Debose, Jan A Burger, Michael Andreeff, Wenbin Liu, Keith A Baggerly, Steven M Kornblau, L Austin Doyle, Elihu H Est

Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms

硼替佐米 (PS-341; NSC 681239) 和阿沃昔布 (flavopiridol; NSC 649890) 治疗复发性或难治性 B 细胞肿瘤患者的 I 期临床试验

Beata Holkova, E Brent Perkins, Viswanathan Ramakrishnan, Mary Beth Tombes, Ellen Shrader, Neha Talreja, Martha D Wellons, Kevin T Hogan, G David Roodman, Domenico Coppola, Loveleen Kang, Jana Dawson, Robert K Stuart, Cody Peer, William D Figg Sr, Sarah Kolla, Austin Doyle, John Wright, Daniel M Sul